Project Grant R35GM155380

Award Date 7/5/24
Completion Date 4/30/29
Dollars Obligated $1.2M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Ithaca, NY 14853, USA
Similar Awards
This $588,426 Project Grant award, provided by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), aims to investigate how transcription factors efficiently locate and bind to specific DNA binding sites within the crowded nucleus of living cells. The project will employ advanced microscopy techniques to precisely track the 3D diffusion, DNA interactions, and target site discrimination of transcription factors involved in...
The federal Project Grant award of $136,661 provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of an innovative high-throughput reporter assay called PADIT-SEQ. This technology will be used to uncover fundamental principles governing transcription factor (TF) binding affinity and specificity to DNA sequences, with the goal of advancing the mechanistic understanding of gene regulation and how noncoding genetic variants...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 - Biomedical Research and Research Training, aims to advance the understanding of how homeodomain (HD) transcription factors (TFs) regulate gene expression and impact human health. The $510,390 award to the Children's Hospital Medical Center in Cincinnati, Ohio will fund a 5-year research program to investigate the mechanisms underlying HD TF DNA binding specificity, the functional impact...
This $685,925 National Science Foundation Project Grant supports research at Georgia Tech Research Corporation to develop novel graph neural networks and machine learning strategies to understand, predict, and design allosteric transcription factors. The NSF Division of Chemistry and Divisions of Chemical, Bioengineering, Environmental and Transport Systems and Information and Intelligent Systems are jointly supporting this work under the Mathematical and Physical Sciences program (CFDA 47.049)....
The National Institute of General Medical Sciences (NIGMS) awarded a $415,252 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of California, Berkeley (UC Berkeley) for the project "PHYSICAL BIOLOGY OF TRANSCRIPTIONAL CONTROL IN EMBRYONIC DEVELOPMENT". The overarching goal is to leverage knowledge about regulatory regions and transcription factors to develop a predictive understanding of the developmental program...
This $100,000 Project Grant awarded by the National Science Foundation (NSF) under the Biological Sciences (CFDA 47.074) program aims to accelerate protein engineering through the integration of cutting-edge artificial intelligence (AI) methods and advanced laboratory automation. The primary objectives are to develop new AI techniques tailored to the unique challenges of protein engineering, and to leverage these AI capabilities to guide the design and discovery of functional proteins with...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $287,488 to The Trustees of Columbia University in the City of New York to develop new methods for understanding how natural proteins can be redesigned as small molecule sensors. The key focus is to establish a technique to quantify how each amino acid in a protein contributes to its folding and binding energetics. This will...
This $1,220,400 Project Grant awarded by the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences supports a collaborative research project between investigators in the U.S. and U.K. to better understand the regulatory mechanisms controlling mammalian gene expression. The project, funded through NSF's Biological Sciences program (CFDA 47.074), aims to define the roles of different DNA regulatory elements and how they work together to precisely control gene expression....
This Project Grant award of $541,574 from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) supports a collaborative research project between the University of Massachusetts Medical School (UMass Medical) and the Israeli Binational Science Foundation. The project aims to investigate the effects of transcription factor binding on the accumulation of UV-induced DNA lesions and mutations within the human genome. Key aspects of the project include developing...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports research to visualize the mechanisms at the intersection of chromatin, transcription, and epigenetics. The $1,525,500 award to Harvard Medical School aims to develop a combinatorial biochemical and structural approach called "Visual Biochemistry" that uses a fully reconstituted chromatin transcription system and time-resolved single-particle...

DECONVOLVING THE LANGUAGE OF PROTEIN BINDING - PROJECT SUMMARY/ABSTRACT THE ABILITY FOR TRANSCRIPTION FACTORS TO ACHIEVE SPECIFICITY IN THE NUCLEUS IS CRITICAL FOR PROPER GENE REGULATION. MIS-TARGETING OF PROTEIN BINDING CAN DISRUPT AN ORGANISM'S ABILITY TO MAINTAIN HOMEOSTASIS AND RESULT IN DISEASE STATES. WHILE SEQUENCE-SPECIFIC TRANSCRIPTION FACTORS OSTENSIBLY DERIVE THEIR SPECIFICITY FOR BINDING BASED ON PREFERENCE TO SPECIFIC DNA PATTERNS (MOTIFS), MULTIPLE CONFOUNDING VARIABLES SUCH AS EPIGENETIC STATE, CO-FACTOR BINDING PARTNERS, AND CHROMATIN ACCESSIBILITY MAKE THE REALITY FAR MORE COMPLICATED. THIS RESEARCH PROGRAM APPLIES A HIGH-THROUGHPUT (ROBOTIC) BIOCHEMICAL GENOMIC APPROACH WITH MACHINE LEARNING ALGORITHMS TO IDENTIFY THE RULES AND MECHANISMS THAT GOVERN THE BINDING OF PROTEINS TO THE GENOME. WE HAVE PREVIOUSLY DEVELOPED MULTIPLE HIGH-RESOLUTION GENOMIC ASSAYS (E.G., CHIP-EXO, PB-EXO, WHIP-EXO) THAT QUANTIFY GENOME-WIDE BINDING OF PROTEINS TO DNA WITH VARYING LEVELS OF REGULATORY FEATURES PRESENT. WE DEMONSTRATED THE UTILITY OF THESE ASSAYS TO UNDERSTAND THE NATIVE BINDING PREFERENCES OF GENERAL REGULATORY FACTORS IN THE YEAST MODEL ORGANISM. THE NEXT STAGE OF THIS RESEARCH WILL BE TO APPLY THESE ASSAYS ON HUMAN TRANSCRIPTION FACTORS IN ULTRA-HIGH THROUGHPUT USING A LIQUID HANDLING ROBOTIC SYSTEM TO IDENTIFY THE MECHANISMS UNDERLYING TRANSCRIPTION FACTOR SEQUENCE SPECIFICITY. THE FIRST MAJOR DIRECTION WILL BE TO DETERMINE THE ABILITY OF PURIFIED TRANSCRIPTION FACTORS TO BIND NAKED DNA GENOME-WIDE (PB-EXO) AND TO EXAMINE HOW THE EPIGENETIC STATUS OF THE DNA CAN CHANGE THE DETECTED BINDING OF A PROTEIN. BY USING GENOMIC DNA SOURCED FROM DIFFERENT CELL STATES, WE WILL BE ABLE TO PRECISELY CHARACTERIZE THE EFFECT OF CELL STATE-SPECIFIC DNA METHYLATION ON PROTEIN BINDING AT BASE-PAIR RESOLUTION. WE WILL ALSO APPLY AI/ML ALGORITHMS THAT WE HAVE DEVELOPED TO CROSS-VALIDATE BIOLOGICAL DISCOVERIES AND MAKE NEW TESTABLE HYPOTHESES. AN ORTHOGONAL AND COMPLEMENTARY APPROACH WILL APPLY THE WHIP-EXO ASSAY TO EXAMINE TRANSCRIPTION FACTOR BINDING SPECIFICITY AGAIN ON NAKED DNA, BUT THIS TIME IN THE CONTEXT OF VARIOUS CELLULAR EXTRACTS. IN ADDITION TO UNCOVERING THE EFFECTS OF CELL-STATE SPECIFIC CO-FACTORS ON PROTEIN BINDING SPECIFICITY, WE WILL ALSO INCORPORATE CHIP-MASS SPECTROMETRY TO IDENTIFY THE CO-FACTORS COMPLEXING WITH TRANSCRIPTION FACTORS OF INTEREST WHEN THEY ARE BOUND TO DNA. THESE ASSAYS WILL PROVIDE DOWNSTREAM TESTABLE HYPOTHESES WITH REGARDS TO WHICH PROTEIN CO- FACTORS ARE RESPONSIBLE FOR MODULATING BINDING SPECIFICITY. THE GOALS OF THIS RESEARCH PROGRAM WILL RESULT IN A DETAILED UNDERSTANDING OF THE FEATURES RESPONSIBLE FOR REGULATING BINDING IN HUNDREDS OF TRANSCRIPTION FACTORS ALONG WITH IDENTITIES OF THE PROTEIN CO-FACTORS THAT MODULATE BINDING.

Posted 7/2/24